216 related articles for article (PubMed ID: 33674865)
1. Conflicting information from the Food and Drug Administration: Missed opportunity to lead standards for safe and effective medical artificial intelligence solutions.
Hernandez-Boussard T; Lundgren MP; Shah N
J Am Med Inform Assoc; 2021 Jun; 28(6):1353-1355. PubMed ID: 33674865
[TBL] [Abstract][Full Text] [Related]
2. Medical devices; exemption from premarket notification and reserved devices; class I. Food and Drug Administration, HHS. Final rule.
Fed Regist; 2000 Jan; 65(10):2296-323. PubMed ID: 11010655
[TBL] [Abstract][Full Text] [Related]
3. Software-Related Recalls of Health Information Technology and Other Medical Devices: Implications for FDA Regulation of Digital Health.
Ronquillo JG; Zuckerman DM
Milbank Q; 2017 Sep; 95(3):535-553. PubMed ID: 28895231
[TBL] [Abstract][Full Text] [Related]
4. Artificial Intelligence in Breast Cancer Screening: Evaluation of FDA Device Regulation and Future Recommendations.
Potnis KC; Ross JS; Aneja S; Gross CP; Richman IB
JAMA Intern Med; 2022 Dec; 182(12):1306-1312. PubMed ID: 36342705
[TBL] [Abstract][Full Text] [Related]
5. Medical devices; exemption from premarket notification and reserved devices; Class I--FDA. Proposed rule.
Fed Regist; 1998 Nov; 63(218):63222-53. PubMed ID: 10187398
[TBL] [Abstract][Full Text] [Related]
6. Medical devices; exemption from premarket notification; class II devices; wheelchair elevator. Final order.
Food and Drug Administration, HHS
Fed Regist; 2013 Mar; 78(42):14013-5. PubMed ID: 23476998
[TBL] [Abstract][Full Text] [Related]
7. Medical devices; exemption from premarket notification; class II devices; powered patient transport. Final order.
Food and Drug Administration, HHS
Fed Regist; 2013 Mar; 78(42):14015-7. PubMed ID: 23476999
[TBL] [Abstract][Full Text] [Related]
8. The 2021 landscape of FDA-approved artificial intelligence/machine learning-enabled medical devices: An analysis of the characteristics and intended use.
Zhu S; Gilbert M; Chetty I; Siddiqui F
Int J Med Inform; 2022 Sep; 165():104828. PubMed ID: 35780651
[TBL] [Abstract][Full Text] [Related]
9. Marketing and US Food and Drug Administration Clearance of Artificial Intelligence and Machine Learning Enabled Software in and as Medical Devices: A Systematic Review.
Clark P; Kim J; Aphinyanaphongs Y
JAMA Netw Open; 2023 Jul; 6(7):e2321792. PubMed ID: 37405771
[TBL] [Abstract][Full Text] [Related]
10. Medical Devices; Exemption From Premarket Notification; Class II Devices; Electric Positioning Chair. Final order.
Food and Drug Administration, HHS
Fed Regist; 2015 Nov; 80(224):72589-91. PubMed ID: 26595944
[TBL] [Abstract][Full Text] [Related]
11. Medical Devices; Exemption From Premarket Notification: Class II Devices; Surgical Apparel. Final order.
Food and Drug Administration, HHS
Fed Regist; 2018 May; 83(96):22846-8. PubMed ID: 30016835
[TBL] [Abstract][Full Text] [Related]
12. Orbital Implants Receiving Food and Drug Administration Premarket Notification.
Corcoran Ruiz KM; Vaishnav YJ; Desautels J; Schaefer JL; Migliori ME; Yilmaz T
Ophthalmic Plast Reconstr Surg; 2022 Sep-Oct 01; 38(5):503-506. PubMed ID: 35699217
[TBL] [Abstract][Full Text] [Related]
13. Medical devices; exemptions from premarket notification and reserved devices; class I--FDA. Notice.
Fed Regist; 1998 Feb; 63(21):5387-93. PubMed ID: 10177333
[TBL] [Abstract][Full Text] [Related]
14. Medical devices; exemptions from premarket notification; class II devices. Final rule.
Food and drug Administration, HHS
Fed Regist; 2001 Nov; 66(221):57368-9. PubMed ID: 11776279
[TBL] [Abstract][Full Text] [Related]
15. Medical devices; exemption from premarket notification requirements; class I devices; technical amendment. Final rule; technical amendment.
Food and Drug Administration. HHS
Fed Regist; 2001 Jul; 66(143):38786-819. PubMed ID: 11725800
[TBL] [Abstract][Full Text] [Related]
16. Medical Device; exemption from premarket notification; class II devices; pharmacy compounding systems. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2001 Mar; 66(55):15796-8. PubMed ID: 11706859
[TBL] [Abstract][Full Text] [Related]
17. Summary of the FDA virtual public workshop on spinal device clinical review held on September 17, 2021.
Devlin VJ; Jean R; Peat CR; Jiang H; Anderson PA; Benson JC; Brodke DS; Golish SR; Kebaish KM; Larson AN; Serhan H
Spine J; 2022 Sep; 22(9):1423-1433. PubMed ID: 35460900
[TBL] [Abstract][Full Text] [Related]
18. Medical devices; exemption from premarket notification; class II devices; triiodothyronine test system. Food and Drug Administration, HHS. Final rule.
Fed Regist; 2000 Oct; 65(202):62285-6. PubMed ID: 11503681
[TBL] [Abstract][Full Text] [Related]
19. An overview of FDA medical device regulation as it relates to deep brain stimulation devices.
Peña C; Bowsher K; Costello A; De Luca R; Doll S; Li K; Schroeder M; Stevens T
IEEE Trans Neural Syst Rehabil Eng; 2007 Sep; 15(3):421-4. PubMed ID: 17894274
[TBL] [Abstract][Full Text] [Related]
20. Medical devices; exemptions from premarket notification; class II devices--FDA, Final rule.
Fed Regist; 1998 Nov; 63(212):59222-31. PubMed ID: 10187384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
